Catherine J. Wu

61.4k total citations · 12 hit papers
270 papers, 14.2k citations indexed

About

Catherine J. Wu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Catherine J. Wu has authored 270 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Immunology, 99 papers in Molecular Biology and 99 papers in Oncology. Recurrent topics in Catherine J. Wu's work include Chronic Lymphocytic Leukemia Research (80 papers), Cancer Immunotherapy and Biomarkers (52 papers) and Immunotherapy and Immune Responses (52 papers). Catherine J. Wu is often cited by papers focused on Chronic Lymphocytic Leukemia Research (80 papers), Cancer Immunotherapy and Biomarkers (52 papers) and Immunotherapy and Immune Responses (52 papers). Catherine J. Wu collaborates with scholars based in United States, Germany and United Kingdom. Catherine J. Wu's co-authors include Sachet A. Shukla, Nir Hacohen, Gad Getz, Michael S. Rooney, Patrick A. Ott, Zhuting Hu, Jerome Ritz, Edward F. Fritsch, Giacomo Oliveira and Robert J. Soiffer and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Catherine J. Wu

252 papers receiving 14.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity

2015 2.5k citations Sachet A. Shukla, Catherine J. Wu et al. profile →
Towards personalized, tumour-specific, therapeutic vaccines for cancer

2017 788 citations Catherine J. Wu et al. profile →
Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

2015 516 citations Sachet A. Shukla, Catherine J. Wu et al. profile →
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer

2016 451 citations Sachet A. Shukla, Catherine J. Wu et al. profile →
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction

2017 406 citations Derin B. Keskin, Wandi Zhang et al. profile →
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma

2017 361 citations Sachet A. Shukla, Gordon J. Freeman et al. profile →
Chronic lymphocytic leukaemia

2017 343 citations Thomas J. Kipps, Catherine J. Wu et al. profile →
Dynamics and specificities of T cells in cancer immunotherapy

2023 293 citations Catherine J. Wu et al. profile →
Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns

2020 280 citations Catherine J. Wu et al. profile →
Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma

2021 224 citations David A. Braun, Catherine J. Wu et al. profile →
Cancer vaccines: Building a bridge over troubled waters

2022 206 citations Catherine J. Wu, Edward F. Fritsch et al. profile →
Dictionary of immune responses to cytokines at single-cell resolution

2023 122 citations Teddy Huang, Shuqiang Li et al. profile →

Peers

Catherine J. Wu

IMMUN

ONCOL

PRM

Giorgio Inghirami United States

Maurilio Ponzoni Italy

Ulrich Keilholz Germany

Qing Yi United States

Gavin P. Dunn United States

Michele Maio Italy

Alberto Órfão Spain

Jonathan Cebon Australia

Julie Teruya‐Feldstein United States

Achim A. Jungbluth United States

Giorgio Inghirami United States

Catherine J. Wu

4.3k ×0.7

IMMUN

8.0k ×1.3

ONCOL

6.1k ×1.1

2.1k ×1.0

2.2k ×1.0

PRM

Citations per year, relative to Catherine J. Wu Catherine J. Wu (= 1×) peers Giorgio Inghirami

Countries citing papers authored by Catherine J. Wu

Since Specialization

Citations

This map shows the geographic impact of Catherine J. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine J. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine J. Wu more than expected).

Fields of papers citing papers by Catherine J. Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine J. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine J. Wu. The network helps show where Catherine J. Wu may publish in the future.

Co-authorship network of co-authors of Catherine J. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine J. Wu. A scholar is included among the top collaborators of Catherine J. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine J. Wu. Catherine J. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Penter, Livius, Katie Maurer, Nicoletta Cieri, et al.. (2025). Mechanisms of immune escape and extramedullary tropism in leukemia cutis. Blood. 147(1). 35–47.

Kim, Haesook T., Vincent T. Ho, Sarah Nikiforow, et al.. (2024). Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis. Transplantation and Cellular Therapy. 30(7). 687.e1–687.e13. 3 indexed citations

Atkins, Michael B., Opeyemi A. Jegede, Naomi B. Haas, et al.. (2023). Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B). Journal for ImmunoTherapy of Cancer. 11(3). e004780–e004780. 19 indexed citations

Denize, Thomas, Yue Hou, Jean‐Christophe Pignon, et al.. (2022). Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma. Clinical Cancer Research. 28(18). 4045–4055. 13 indexed citations

Penter, Livius, Elisa ten Hacken, Jackson Southard, et al.. (2022). Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor Models. Cancer Research. 83(5). 667–672. 6 indexed citations

Pan, Heng, Loïc Renaud, Ronan Chaligné, et al.. (2021). Discovery of Candidate DNA Methylation Cancer Driver Genes. Cancer Discovery. 11(9). 2266–2281. 53 indexed citations

Penter, Livius, Satyen H. Gohil, Caleb A. Lareau, et al.. (2021). Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History. Cancer Discovery. 11(12). 3048–3063. 45 indexed citations

Maurer, Katie, Haesook T. Kim, Utkarsh Acharya, et al.. (2021). COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience. Blood Advances. 5(3). 861–871. 24 indexed citations

McGrail, Daniel J., Ming Sun, Dan Qi, et al.. (2020). Integrated Genomic Characterization of the Human Immunome in Cancer. Cancer Research. 80(21). 4854–4867. 10 indexed citations

10.

Trinh, Anne, Carlos R. Gil Del Alcazar, Sachet A. Shukla, et al.. (2020). Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System. Molecular Cancer Research. 19(4). 623–635. 24 indexed citations

11.

Ficial, Miriam, Opeyemi A. Jegede, Yue Hou, et al.. (2020). Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma. Clinical Cancer Research. 27(5). 1371–1380. 51 indexed citations

12.

Wang, Ninghai, Elisa ten Hacken, Shih‐Shih Chen, et al.. (2019). SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer. Cancer Immunology Research. 7(9). 1485–1496. 42 indexed citations

13.

Zhang, Hongyi, Longchao Liu, Jian Zhang, et al.. (2019). Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers. Clinical Cancer Research. 26(6). 1359–1371. 99 indexed citations

14.

Mahoney, Kathleen M., Sachet A. Shukla, Nikolaos Patsoukis, et al.. (2018). A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression. Cancer Immunology Immunotherapy. 68(3). 421–432. 112 indexed citations

15.

Shalek, Alex K., Jellert T. Gaublomme, Lili Wang, et al.. (2012). Nanowire-Mediated DeliveryEnables Functional Interrogationof Primary Immune Cells: Application to the Analysis of Chronic LymphocyticLeukemia. Europe PMC (PubMed Central). 142 indexed citations

16.

Cai, Ann, Derin B. Keskin, David S. DeLuca, et al.. (2012). Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients. Clinical Cancer Research. 18(20). 5761–5772. 40 indexed citations

17.

Brown, Jennifer R., Megan Hanna, Bethany Tesar, et al.. (2012). Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 18(14). 3791–3802. 59 indexed citations

18.

Biernacki, Melinda A., Ovidiu Marina, Wandi Zhang, et al.. (2010). Efficacious Immune Therapy in Chronic Myelogenous Leukemia (CML) Recognizes Antigens That Are Expressed on CML Progenitor Cells. Cancer Research. 70(3). 906–915. 43 indexed citations

19.

Marina, Ovidiu, Ursula Hainz, Melinda A. Biernacki, et al.. (2010). Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens. Cancer Research. 70(4). 1344–1355. 28 indexed citations

20.

Zhang, Wandi, Wanyong Zeng, Shelby A. Rogers, et al.. (2010). Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion. Clinical Cancer Research. 16(10). 2729–2739. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact